{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:27:21Z","timestamp":1776652041570,"version":"3.51.2"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003007","name":"Ministry of Scientific Research, Egypt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003007","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejpb.2018.06.027","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T08:53:08Z","timestamp":1530175988000},"page":"152-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Inhalable multi-compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor\/herbal combined therapy of lung carcinoma"],"prefix":"10.1016","volume":"130","author":[{"given":"Dalia M.","family":"Kabary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maged W.","family":"Helmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsayeda-Zeinab A.","family":"Abdelfattah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-You","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadria A.","family":"Elkhodairy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed O.","family":"Elzoghby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.06.027_b0005","first-page":"55","article-title":"Nanotechnology-based inhalation treatments for lung cancer: state of the art","volume":"8","author":"Ahmad","year":"2015","journal-title":"Nanotechnol. Sci. Appl."},{"key":"10.1016\/j.ejpb.2018.06.027_b0010","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.biomaterials.2008.03.033","article-title":"Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer","volume":"29","author":"Tseng","year":"2008","journal-title":"Biomaterials"},{"issue":"35","key":"10.1016\/j.ejpb.2018.06.027_b0015","first-page":"5211","article-title":"Polymeric nanocarriers as robust platforms for cancer therapy","volume":"23","author":"Elzoghby","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"35","key":"10.1016\/j.ejpb.2018.06.027_b0020","first-page":"5213","article-title":"Self-assembled nanocarriers based on amphiphilic natural polymers for anti-cancer drug delivery applications","volume":"23","author":"Sabra","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"35","key":"10.1016\/j.ejpb.2018.06.027_b0025","first-page":"5261","article-title":"Zein-based nanocarriers as potential natural alternatives for drug and gene delivery: focus on cancer therapy","volume":"23","author":"Elzoghby","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejpb.2018.06.027_b0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.015","article-title":"To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine?","volume":"244","author":"Danhier","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.06.027_b0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.colsurfb.2008.01.016","article-title":"Preparation and properties of inhalable nanocomposite particles: effects of the size, weight ratio of the primary nanoparticles in nanocomposite particles and temperature at a spray-dryer inlet upon properties of nanocomposite particles","volume":"64","author":"Tomoda","year":"2008","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2018.06.027_b0040","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jconrel.2017.11.036","article-title":"Inhalable particulate drug delivery systems for lung cancer therapy: nanoparticles, microparticles, nanocomposites and nanoaggregates","volume":"269","author":"Abdelaziz","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.06.027_b0045","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2125.2003.01893.x","article-title":"Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.06.027_b0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2006.03.052","article-title":"Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles","volume":"319","author":"Azarmi","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.06.027_b0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1208\/s12249-015-0317-x","article-title":"Devices for dry powder drug delivery to the lung","volume":"16","author":"Berkenfeld","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2018.06.027_b0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.trac.2015.12.016","article-title":"Solid lipid-based nanocarriers as efficient targeted drug and gene delivery systems","volume":"77","author":"Dolatabadi","year":"2016","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.ejpb.2018.06.027_b0065","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.2217\/nnm-2017-0247","article-title":"Shell-crosslinked zein nanocapsules for oral codelivery of exemestane and resveratrol in breast cancer therapy","volume":"12","author":"Elzoghby","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2018.06.027_b0070","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.drudis.2012.05.010","article-title":"Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy","volume":"17","author":"Parhi","year":"2012","journal-title":"Drug Disc. Today"},{"issue":"5","key":"10.1016\/j.ejpb.2018.06.027_b0075","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2217\/nnm-2017-0301","article-title":"Phytosomal bilayer-enveloped casein micelles for codelivery of monascus yellow pigments and resveratrol to breast cancer","volume":"13","author":"El-Far","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2018.06.027_b0080","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature03794","article-title":"Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system","volume":"436","author":"Sengupta","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2018.06.027_b0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.actbio.2016.05.012","article-title":"PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy","volume":"39","author":"Choi","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2018.06.027_b0090","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3816\/CLC.2008.n.049","article-title":"The role of targeting mammalian target of rapamycin in lung cancer","volume":"9","author":"Pal","year":"2008","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.ejpb.2018.06.027_b0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/mc.20453","article-title":"p53 cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo","volume":"48","author":"Katiyar","year":"2009","journal-title":"Mol. Carcinogen."},{"key":"10.1016\/j.ejpb.2018.06.027_b0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1475-2867-14-49","article-title":"Berberine-induced apoptotic and autophagic death of HepG2 cells requires AMPK activation","volume":"14","author":"Yu","year":"2014","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejpb.2018.06.027_b0105","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.3892\/mmr.2014.2608","article-title":"Berberine sensitizes rapamycin-mediated human hepatoma cell death in vitro","volume":"10","author":"Guo","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejpb.2018.06.027_b0110","first-page":"3049","article-title":"Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin","volume":"6","author":"Sun","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2018.06.027_b0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.06.027_b0120","first-page":"1106","article-title":"Multicompartimental nanoparticles for co-encapsulation and multimodal drug delivery to tumor cells and neovasculature","volume":"31","author":"Mendes","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.06.027_b0125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2017.06.077","article-title":"Superiority of aromatase inhibitor and cyclooxygenase-2 inhibitor combined delivery: hyaluronate-targeted versus PEGylated protamine nanocapsules for breast cancer therapy","volume":"529","author":"Elzoghby","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.06.027_b0130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.carbpol.2013.11.009","article-title":"Layer-by-layer coated lipid\u2013polymer hybrid nanoparticles designed for use in anticancer drug delivery","volume":"102","author":"Ramasamy","year":"2014","journal-title":"Carbohyd. Polym."},{"key":"10.1016\/j.ejpb.2018.06.027_b0135","doi-asserted-by":"crossref","first-page":"9565","DOI":"10.1039\/C6NJ02539K","article-title":"Design and synthesis of new s-triazine polymers and their application as nanoparticulate drug delivery systems","volume":"40","author":"Khattab","year":"2016","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejpb.2018.06.027_b0140","first-page":"45","article-title":"Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles","volume":"62","author":"Rivolta","year":"2011","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.06.027_b0145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2015.06.015","article-title":"Swellable floating tablet based on spray-dried casein nanoparticles: near-infrared spectral characterization and floating matrix evaluation","volume":"491","author":"Elzoghby","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.06.027_b0150","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot077446","article-title":"Induction of lung tumors in mice with urethane","volume":"2015","author":"Gurley","year":"2015","journal-title":"Cold Spring Harbor Protoc."},{"key":"10.1016\/j.ejpb.2018.06.027_b0155","first-page":"940","article-title":"Development and characterization of aspirin-phospholipid complex for improved drug delivery","volume":"3","author":"Semalty","year":"2010","journal-title":"Int. J. Pharm. Sci. Nanotechnol."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2018.06.027_b0160","first-page":"18","article-title":"Self-assembled phospholipid-based phytosomal nanocarriers as promising platforms for improving oral bioavailability of the anticancer celastrol","volume":"535","author":"Freag","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.06.027_b0165","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1517\/17425240902967607","article-title":"Pharmacosomes: the lipid-based new drug delivery system","volume":"6","author":"Semalty","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2018.06.027_b0170","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1007\/s11095-017-2207-2","article-title":"Multi-reservoir phospholipid shell encapsulating protamine nanocapsules for co-delivery of letrozole and celecoxib in breast cancer therapy","volume":"34","author":"Elzoghby","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.06.027_b0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2013.02.025","article-title":"Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives","volume":"168","author":"Khan","year":"2013","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2018.06.027_b0180","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2017.10.043","article-title":"PEGylated Lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: design, characterization and its cytotoxic effect","volume":"536","author":"Lin","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.06.027_b0185","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.2174\/1381612822999160511151612","article-title":"Editorial (Thematic Issue: Nanocarriers Based on Natural Polymers as Platforms for Drug and Gene Delivery Applications)","volume":"22","author":"Elzoghby","year":"2016","journal-title":"Curr. Pharm Des."},{"key":"10.1016\/j.ejpb.2018.06.027_b0190","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.carbpol.2018.01.095","article-title":"Laminated chitosan-based composite sponges for transmucosal delivery of novel protamine-decorated tripterine phytosomes: ex-vivo mucopenetration and in-vivo pharmacokinetic assessments","volume":"188","author":"Freag","year":"2018","journal-title":"Carbohyd. Polym."},{"key":"10.1016\/j.ejpb.2018.06.027_b0195","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.colsurfb.2018.05.008","article-title":"Hyaluronate\/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma","volume":"169","author":"Kabary","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2018.06.027_b0200","first-page":"5283","article-title":"Hyaluronate-lipid nanohybrids: fruitful harmony in cancer targeting","volume":"23","author":"Freag","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejpb.2018.06.027_b0205","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s10637-017-0555-8","article-title":"A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer","volume":"36","author":"Alamgeer","year":"2018","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.ejpb.2018.06.027_b0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-5173(88)90177-9","article-title":"Effect of powder inhaler design on drug deposition in the respiratory tract","volume":"42","author":"Vidgren","year":"1988","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.06.027_b0215","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1080\/07373939808917460","article-title":"Microencapsulation by spray drying","volume":"16","author":"R\u00e9","year":"1998","journal-title":"Dry. Technol."},{"key":"10.1016\/j.ejpb.2018.06.027_b0220","first-page":"1","article-title":"Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer","author":"Bakhtiary","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2018.06.027_b0225","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/17425247.4.3.297","article-title":"Design of fine particles for pulmonary drug delivery","volume":"4","author":"Weers","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2018.06.027_b0230","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.lwt.2015.07.027","article-title":"Effect of operating conditions on the yield and quality of a\u00e7ai (Euterpe oleracea Mart.) powder produced in spouted bed","volume":"64","author":"Costa","year":"2015","journal-title":"LWT-Food Sci. Technol."},{"key":"10.1016\/j.ejpb.2018.06.027_b0235","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1080\/07373937.2013.788019","article-title":"Designing a multicomponent spray-dried formulation platform for pulmonary delivery of biomacromolecules: the effect of polymers on the formation of an amorphous matrix for glassy state stabilization of biomacromolecules","volume":"31","author":"Sou","year":"2013","journal-title":"Dry. Technol."},{"key":"10.1016\/j.ejpb.2018.06.027_b0240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0301-4622(99)00150-7","article-title":"Surface properties of aqueous solutions of L-leucine","volume":"84","author":"Gli\u0144ski","year":"2000","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.ejpb.2018.06.027_b0245","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/pharmaceutics6010185","article-title":"Encapsulation of alcohol dehydrogenase in mannitol by spray drying","volume":"6","author":"Shiga","year":"2014","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2018.06.027_b0250","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.powtec.2015.10.008","article-title":"Designing a multi-component spray-dried formulation platform for pulmonary delivery of biopharmaceuticals: the use of polyol, disaccharide, polysaccharide and synthetic polymer to modify solid-state properties for glassy stabilisation","volume":"287","author":"Sou","year":"2016","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2018.06.027_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2006.08.014","article-title":"Conformational analysis of protein secondary structure during spray-drying of antibody\/mannitol formulations","volume":"65","author":"Sch\u00fcle","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.06.027_b0260","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/02652048.2011.599437","article-title":"Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid","volume":"28","author":"Pourshahab","year":"2011","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2018.06.027_b0265","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11095-017-2281-5","article-title":"Effects of moisture-induced crystallization on the aerosol performance of spray dried amorphous ciprofloxacin powder formulations","volume":"35","author":"Shetty","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.06.027_b0270","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3109\/03639045.2014.956111","article-title":"Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance","volume":"41","author":"Ezzati Nazhad Dolatabadi","year":"2015","journal-title":"Drug Develop. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2018.06.027_b0275","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2015.03.015","article-title":"Bio-inspired pulmonary surfactant-modified nanogels: a promising siRNA delivery system","volume":"206","author":"De Backer","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.06.027_b0280","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejpb.2018.06.027_b0285","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/01480545.2011.589437","article-title":"Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators","volume":"35","author":"Hamsa","year":"2012","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.ejpb.2018.06.027_b0290","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejphar.2017.11.013","article-title":"Berberine protects acute liver failure in mice through inhibiting inflammation and mitochondria-dependent apoptosis","volume":"819","author":"Xu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.06.027_b0295","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejpb.2018.04.023","article-title":"Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer","volume":"128","author":"Sabra","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118305009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118305009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:33:20Z","timestamp":1760546000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118305009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":59,"alternative-id":["S0939641118305009"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.06.027","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhalable multi-compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor\/herbal combined therapy of lung carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}